Obesity and breast cancer: Linking inflammation to aromatase activity in cancer progression and therapy resistance
MetadataShow full item record
Breast cancer affects an increasing number of women every year, and a major risk factor for this disease is obesity. I studied the connection between breast cancer progression and an obese microenvironment in ER+ breast cancer, which requires estrogen to grow. For one, consumption of energy and nutrients in excess of what is required by the body helps to fulfill a growing tumor's high energy demands. At the same time, accumulation of fat tissue not only allows for storage of excess energy, but also forms an endocrine tissue, providing hormones and growth factors that support tumor growth. Another way in which I found that obesity supports a tumor is by creating a chronic state of inflammation in the body. The tumor can manipulate the inflammatory environment to hide from the immune system, grow blood vessels, invade other tissues, and eventually spread to other organs. One type of immune cell called macrophages is found in the tumor environment and seems to produce a compound called PGE2, which stimulates the activity of aromatase. This enzyme plays an important role in the synthesis of estrogens. Based on my findings, I believe that obesity assists the cancer in sustaining an inflammatory environment full of macrophages releasing PGE2. High amounts of this compound then lead to stimulation of aromatase, and synthesis of greater amounts of estrogen. The tumor can use these estrogens to grow and progress to a more advanced stage. This knowledge can help us to discover more effective future treatments. Currently, breast cancer patients usually receive a primary treatment coupled with hormone therapy, which targets for example aromatase to disrupt estrogen synthesis and prevent cancer growth. However, many women are already therapy-resistant or become therapy-resistant over time, leading to a high potential for future relapse. More research is needed into the mechanisms behind resistance to aromatase inhibitors and other hormonal treatments. Additionally, factors such as a patient's weight, metabolic health, and potential inflammation, should be taken into account when conducting a risk assessment in the clinic, seeing as obesity has been linked to a greater breast cancer risk and cancer progression.
Showing items related by title, author, creator and subject.
Voice quality, vocal performance and swallowing ability in early laryngeal cancer patients; a comparison before and after cancer treatment Sluis, K.E. van (2014)Advancement in early laryngeal cancer management led to excellent tumor control. Secondary outcomes such as voice quality and health-related quality of life are of growing importance. Purpose of this study was to investigate ...
Diabetes, insulin and cancer risk The molecular role of insulin signaling and hyperinsulinemia in cancer development and progression in diabetes patients Dopper, I. (2014)The relationship between diabetes and the risk for cancer development seems to be more and more confirmed. An important link between these two is the hyperinsulinemia found both in patients with T1DM and patients with T2DM. ...